Data Bridge Market Research analyses that the pneumoconiosis market was valued at USD 235.85 million in 2021 and is expected to reach USD 414.41 million by 2029, registering a CAGR of 7.30% during the forecast period of 2022 to 2029.

Pneumoconiosis is a restrictive and occupational lung disease caused by inhalation of dust. There are a number of different agents that, when inhaled, can potentially cause pneumoconiosis.